This is a preview of subscription content, log in via an institution to check access.
Notes
Comparative Effectiveness Public Advisory Council
References
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document for the Assessment of Esketamine for Treatment-Resistant Depression Internet Document : 31 Oct 2018. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-review-posts-draft-scoping-document-for-the-assessment-of-esketamine-for-treatment-resistant-depression/
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document for the Assessment of Siponimod for the Treatment of Secondary Progressive Multiple Sclerosis Internet Document : 31 Oct 2018. Available from: URL: https://icer-review.org/announcements/institute-for-clinical-and-economic-review-posts-draft-scoping-document-for-the-assessment-of-siponimod-for-the-treatment-of-secondary-progressive-multiple-sclerosis/
Rights and permissions
About this article
Cite this article
ICER posts draft documents on esketamine and siponimod. PharmacoEcon Outcomes News 816, 3 (2018). https://doi.org/10.1007/s40274-018-5423-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5423-z